Global Live Cell Imaging Markets, 2020-2025 - Growing Adoption of High-Content Screening Techniques in Drug Discovery
Dublin, Nov. 11, 2020 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The Global Live Cell Imaging Market Size is Projected to Reach USD 2.8 Billion by 2025 from USD 1.8 Billion in 2020, at a CAGR of 8.8% during the Forecast Period.
The market for live cell imaging is driven primarily by the factors such as the growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, growth in research funding, and rising government funding in regenerative medicine research. However, high cost of high-content screening systems will hinder the overall adoption of live cell imaging systems and thereby restrain market growth in the coming years.
By instrument type, the microscopes segment holds the largest market share during the forecast period.
Based on type, the live cell imaging instruments market is segmented into microscopes, standalone systems, cell analyzers, and accessories. The microscopes segment accounted for the largest share of the live cell imaging market in 2019. The large share of this segment can be attributed to the increasing studies into cell behavior and the need to correlate multiple events and markers with cell morphology, favorable funding scenario for R&D in microscopy, rising focus on regenerative medicine, technological advancements in microscopes, and favorable regulatory procedures to launch new instruments in the market.
By application, the stem cells segment is expected to register the highest CAGR during the forecast period.
Based on application, the live cell imaging market is segmented into cell biology, stem cells, developmental biology, and drug discovery. The stem cells segment is projected to register the highest CAGR during the forecast period. Factors such as increasing stem cell research activities and investments.
Asia Pacific (APAC) is projected to witness the highest growth during the forecast period.
The APAC market is estimated to register the highest CAGR during the forecast period. The growth in this market can be attributed to the government initiatives for research on stem cell therapy, increasing aging population, the rising prominence of regenerative medicine research, increasing number of researchers in Japan, growth of preclinical/clinical research in China, favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry in India, and growth of the pharmaceutical and biopharmaceutical sectors in South Korea.
Market Dynamics
Drivers
Growing Adoption of High-Content Screening Techniques in Drug Discovery
Rising Incidence of Cancer
Growing Availability of Research Funds
Rising Government Funding in Regenerative Medicine Research
Restraints
High Cost of High-Content Screening Systems
Opportunities
Emerging Markets
Applications of Hcs in Personalized Medicine
Challenges
Maintaining Cell Viability and the Cellular Environment in Cell Cultures
Dearth of Skilled Professionals
COVID-19 Impact on the Live Cell Imaging Market
Companies Mentioned
Becton, Dickinson and Company
Biotek Instruments, Inc.
Bruker Corporation
Carl Zeiss Ag
Cytosmart Technologies
Danaher Corporation
Etaluma, Inc.
GE Healthcare
Keyence Corporation
Logos Biosystems (Aligned Genetics Inc.)
Merck KGaA
Nanoentek Inc.
Nanolive Sa
Nikon Corporation
Olympus Corporation
Perkinelmer Inc.
Phase Focus Ltd.
Sartorius Ag
Sony Biotechnology Inc.
Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/j2lu71
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900